Advantages and Disadvantages of Increasing Pharmaceutical R&D Outsourcing to India and China

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

The objective of this research service is to provide detailed analysis of Pharmaceutical R&D outsourcing to India and China.

Table of Contents

Advantages and Disadvantages of Increasing Pharmaceutical R&D Outsourcing to India and China, Executive SummaryExecutive SummarySummary of Advantages and Disadvantages of Increasing Pharmaceutical R&D Outsourcing to India and ChinaAdvantages and Disadvantages of Increasing Pharmaceutical R&D Outsourcing to India and China, Key Definitions and AbbreviationsKey DefinitionsKey DefinitionsAbbreviationsAbbreviationsAdvantages and Disadvantages of Increasing Pharmaceutical R&D Outsourcing to India and China, R&D Outsourcing in Pharmaceutical IndustryIntroductionOverviewDrug Development ProcessCritical Factors for Clinical Studies OutsourcingPharmaceutical R&DOutsourcingAdvantages and Disadvantages of Increasing Pharmaceutical R&D Outsourcing to India and China, R&D Outsourcing to IndiaR&D Outsourcing to IndiaIndian Industry LandscapeClinical Trials in India - RegulationsSWOT AnalysisKey TrendsMarket Engineering ResearchKey Market Engineering MeasurementsOutsourced Clinical Research Market ForecastsCRO ProfilesContract Research Organisations Pharmaceutical Company ProfilesInternational Pharmaceutical CompaniesAdvantages and Disadvantages of Increasing Pharmaceutical R&D Outsourcing to India and China, R&D Outsourcing to ChinaR&D Outsourcing to ChinaChinese Industry LandscapeClinical Trials in China - RegulationsSWOT AnalysisKey TrendsCRO ProfilesContract Research OrganisationsPharmaceutical Company ProfilesInternational Pharmaceutical CompaniesAdvantages and Disadvantages of Increasing Pharmaceutical R&D Outsourcing to India and China, Strategic Analysis and RecommendationsStrategic AnticipationStrategic AnticipationPotential ThreatsThreats for Clinical Research Outsourcing to India and ChinaClinical ResearchOpportunities Clinical Research to India and ChinaPatient AvailabilityInvestigatorsClinical Trials in India and ChinaAdvantages and Disadvantages of Increasing Pharmaceutical R&D Outsourcing to India and China, Frost & Sullivan AwardsFrost & Sullivan AwardsIntroductionCustomer Service Leadership AwardCompetitive Strategy Leadership AwardAdvantages and Disadvantages of Increasing Pharmaceutical R&D Outsourcing to India and China, Decision Support DatabasesPharmaceutical R&D ExpenditurePharmaceutical R&D ExpenditurePercentage Pharmaceutical R&D ExpenditureDecision Support Database - India and ChinaKey Macroeconomic Facts




Related Research

Release Date : 18-Sep-17

Region : Europe

Release Date : 15-Sep-17

Region : Europe

Release Date : 08-Sep-17

Region : Europe

Release Date : 06-Sep-17

Region : Europe

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.